Loading…
Thyrocare Technologies (THYROCARE)₹485.30−2.74%Healthcare Service Provider
At the end of the Sep 2026 quarter, Thyrocare Technologies' shareholders were: promoters 51.06%, FIIs 9.38%, DIIs 25.96%, public 13.60%. Promoter holding is down 9.90 percentage points from 60.96% a quarter earlier. FII holding is up 4.52 percentage points from 4.86% a year earlier. 99.98% of promoter shares were pledged. It had 75,150 shareholders.
As of · Company filings (shareholding pattern)
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 71.15% | 71.15% | 71.15% | 71.15% | 71.10% | 71.10% | 71.10% | 71.10% | 60.97% | 60.96% | 60.96% | 51.06% |
| FIIs | 3.36% | 2.91% | 2.50% | 1.94% | 2.78% | 2.42% | 3.24% | 4.86% | 4.97% | 5.38% | 5.44% | 9.38% |
| DIIs | 13.93% | 14.92% | 14.93% | 14.83% | 14.72% | 15.01% | 14.58% | 13.51% | 20.56% | 21.04% | 20.96% | 25.96% |
| Public | 11.56% | 11.02% | 11.42% | 12.08% | 11.40% | 11.47% | 11.08% | 10.53% | 13.50% | 12.62% | 12.64% | 13.60% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 99.98% |
| Number of shareholders | 68,811 | 64,792 | 61,607 | 59,349 | 56,639 | 57,376 | 54,540 | 54,116 | 77,582 | 73,342 | 73,029 | 75,150 |
| Holder | Category | Sep 2026 | Change (pp) |
|---|---|---|---|
| API Holdings Limited | Promoter | 51.04% | New |
| Hsbc Mutual Fund - Hsbc Aggressive Hybrid Fund | DII | 6.75% | New |
| Nippon Life India Trustee Ltd-A/C Nippon India Pharma Fund | DII | 5.61% | New |
| Icici Prudential Mutual Fund - Icici Prudential Active Momentum Fund | DII | 3.69% | New |
| Aditya Birla Sun Life Mutual Fund - Aditya Birla Sun Life Business Cycle Fund | DII | 3.48% | New |
| Kotak Mahindra Life Insurance Company Ltd. | DII | 1.56% | New |
| Docon Technologies Private Limited | Promoter | Exited | −60.87 |
| Nippon Life India Trustee Ltd-A/C Nippon India Small Cap Fund | DII | Exited | — |
| Icici Prudential Pharma Healthcare And Diaganostics (P.H.D) Fund | DII | Exited | — |
| Hsbc Mutual Fund - Hsbc Midcap Fund | DII | Exited | — |
| Aditya Birla Sun Life Trustee Private Limited A/C - Aditya Birla Sun Life Elss Tax Saver Fund | DII | Exited | — |
Promoters held 51.06% of Thyrocare Technologies at the end of the Sep 2026 quarter, down 20.04 percentage points from 71.10% a year earlier.
In the Sep 2026 quarter, foreign institutional investors (FIIs) held 9.38% (up 3.94 percentage points from 5.44% a quarter earlier) and domestic institutions (DIIs) held 25.96% (up 5.00 percentage points from 20.96% a quarter earlier).
Yes. 99.98% of promoter shares were pledged at the end of the Sep 2026 quarter.
Thyrocare Technologies had 75,150 shareholders at the end of the Sep 2026 quarter, against 54,116 a year earlier.
Hsbc Mutual Fund - Hsbc Aggressive Hybrid Fund (DII) held 6.75% at the end of the Sep 2026 quarter, the largest named holding outside the promoter group.